As of June 30, 2026, Valbiotis SA carries a market capitalization of 28.46M, placing it among publicly traded companies globally. Its enterprise value stands at 21.03M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 28.46M |
| Enterprise Value | 21.03M |
Valbiotis SA's next confirmed earnings release is scheduled for March 17, 2027.
| Earnings Date | 3/17/2027 |
As of June 30, 2026, Valbiotis SA has 35.49M shares outstanding.
| Shares Outstanding | 35.49M |
These figures are as of June 30, 2026.
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.53 |
As of June 30, 2026, Valbiotis SA maintains a current ratio of 3.58, meaning it holds 3.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.58 |
| Quick Ratio | 2.67 |
| Debt / Equity | 34.33 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 50.00 |
As of the close on November 17, 2026, Valbiotis SA's stock has gained approximately 1.85% over the past 52 weeks. The 50-day moving average sits at 0.65, while the 200-day moving average is 0.86.
| 52-Week Price Change | 1.85% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.86 |
As of June 30, 2026, Valbiotis SA holds 11.73M in cash and equivalents against 4.30M in total debt, resulting in a net debt position of -8.50M. Total book value stands at 12.52M, with working capital of 11.36M providing operational flexibility.
| Cash & Cash Equivalents | 11.73M |
| Total Debt | 4.30M |
| Net Debt | -8.50M |
| Equity (Book Value) | 12.52M |
| Book Value Per Share | 0.35 |
| Working Capital | 11.36M |
Valbiotis SA's most recent stock split took place on June 10, 2026 with a 178:181 split ratio.
| Last Split Date | 6/10/2026 |
| Split Ratio | 178:181 |
Already premium?